INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524804	ISIN Demat INE406A01037	Book Value 350.46	NSE Symbol AUROPHARMA	Dividend Yield (%) 0	Market Cap (₹ Cr.) 63,920.04	P/E 36.6	EPS 29.81	Face Value 1

Particulars (₹ Cr)	Jun 2025	Mar 2025	Dec 2024	Sep 2024

Gross Sales/Income from operations	2822.14	2721.43	2883.56	2757.88
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,822.14	2,721.43	2,883.56	2,757.88
Other Operating Income	26.03	10.56	33.07	66.71
Total Income from operations (net)	2,848.17	2,731.99	2,916.63	2,824.59
Total Expenses	2,121.85	2,229.36	2,271.76	2,171.87
Cost of Sales	1,392.87	1,437.53	1,464.28	1,409.65
Employee Cost	282.97	273.11	265.15	265.48
Depreciation, amortization and depletion expense	70.02	93.88	68.28	68.16
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	375.99	424.84	474.05	428.58
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	726.32	502.63	644.87	652.72
Other Income	83.77	113.98	54.26	122.66
Profit from ordinary activities before finance costs and exceptional items	810.09	616.61	699.13	775.38
Finance Costs	60.00	61.09	66.19	51.63
Profit from ordinary activities after finance costs but before exceptional items	750.09	555.52	632.94	723.75
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	750.09	555.52	632.94	723.75
Total Tax	190.96	147.35	160.89	186.22
Net profit from Ordinary Activities After Tax	559.13	408.17	472.05	537.53
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	559.13	408.17	472.05	537.53
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	559.13	408.17	472.05	537.53
Other Comprehensive Income	-1.32	-0.91	-1.45	-2.48
Total Comprehensive Income	557.81	407.26	470.60	535.05
Equity	58.08	58.08	58.08	58.08
Reserve & Surplus	0.00	0.00	0.00	19,598.16
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	9.63	7.03	8.13	9.21
EPS before Exceptional/Extraordinary items-Diluted	9.63	7.03	8.13	9.21
EPS after Exceptional/Extraordinary items-Basic	9.63	7.03	8.13	9.21
EPS after Exceptional/Extraordinary items-Diluted	9.63	7.03	8.13	9.21
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00